» Articles » PMID: 33407952

Circ_0000396 Inhibits Rheumatoid Arthritis Synovial Fibroblast Growth and Inflammatory Response Via MiR-203/HBP1 Axis

Overview
Specialty Biology
Date 2021 Jan 7
PMID 33407952
Citations 8
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Circ_0000396 was found to be down-regulated in the rheumatoid arthritis (RA) patients and had a high diagnostic value. However, the function and mechanisms underlying circ_0000396 in RA progression remain unclear.

Methods: The expression of circ_0000396, microRNA (miR)-203 and HMG-box transcription factor 1 (HBP1) was detected using qRT-PCR and western blot. The proliferative and apoptotic capabilities of rheumatoid arthritis synovial fibroblasts (RASFs) were measured by colony formation, CCK-8, flow cytometry and western blot assays, respectively. The levels of interleukins (IL)-6, IL-1β, IL-8 and tumor necrosis factor-α (TNF-α) were detected using enzyme-linked immunosorbent assay (ELISA). The target correlations between miR-203 and circ_0000396 or HBP1 were validated using pull-down and dual-luciferase reporter assay.

Results: Circ_0000396 was decreased in RA synovial tissues and RASFs, and overexpression of circ_0000396 suppressed cell proliferation, induced cell apoptosis and reduced the release of inflammatory cytokine IL-6, IL-1β, IL-8 and TNF-α in RASFs, while circ_0000396 deletion functioned oppositely. MiR-203 was confirmed to be a target of circ_0000396, and miR-203 reversed the protective effects of circ_0000396 on the dysfunction and inflammation of RASFs. HBP1 was a target of miR-203, and silencing miR-203 inhibited RASFs malignant changes by regulating HBP1. In addition, circ_0000396 could regulate HBP1 by sponging miR-203, and HBP1 decrease attenuated the effects of circ_0000396 on RASF growth and inflammation.

Conclusion: Circ_0000396 inhibited the growth and inflammation in RASFs by regulating miR-203/HBP1 axis, providing a potential therapeutic target for RA.

Citing Articles

Unveiling Novel Drug Targets and Emerging Therapies for Rheumatoid Arthritis: A Comprehensive Review.

Khokhar M, Dey S, Tomo S, Jaremko M, Emwas A, Pandey R ACS Pharmacol Transl Sci. 2024; 7(6):1664-1693.

PMID: 38898941 PMC: 11184612. DOI: 10.1021/acsptsci.4c00067.


Exosomes and exosomal miRNAs: A new avenue for the future treatment of rheumatoid arthritis.

Liu Y, Jiang P, Qu Y, Liu C, Zhang D, Xu B Heliyon. 2024; 10(6):e28127.

PMID: 38533025 PMC: 10963384. DOI: 10.1016/j.heliyon.2024.e28127.


Circ_0000396 suppresses the proliferation and inflammation of rheumatoid arthritis synovial fibroblasts by targeting miR-574-5p/RSPO1 axis.

Yu H, Yang J, Chen K, Kang W, Zhu F J Orthop Surg Res. 2023; 18(1):718.

PMID: 37737195 PMC: 10514958. DOI: 10.1186/s13018-023-04117-5.


Biomarkers (mRNAs and non-coding RNAs) for the diagnosis and prognosis of rheumatoid arthritis.

Jiang Y, Zhong S, He S, Weng J, Liu L, Ye Y Front Immunol. 2023; 14:1087925.

PMID: 36817438 PMC: 9929281. DOI: 10.3389/fimmu.2023.1087925.


Newly discovered circRNAs in rheumatoid arthritis, with special emphasis on functional roles in inflammatory immunity.

Li Z, Wang J, Lin Y, Fang J, Xie K, Guan Z Front Pharmacol. 2022; 13:983744.

PMID: 36278188 PMC: 9585171. DOI: 10.3389/fphar.2022.983744.


References
1.
Huber L, Distler O, Tarner I, Gay R, Gay S, Pap T . Synovial fibroblasts: key players in rheumatoid arthritis. Rheumatology (Oxford). 2006; 45(6):669-75. DOI: 10.1093/rheumatology/kel065. View

2.
Altesha M, Ni T, Khan A, Liu K, Zheng X . Circular RNA in cardiovascular disease. J Cell Physiol. 2018; 234(5):5588-5600. DOI: 10.1002/jcp.27384. View

3.
Mori T, Miyamoto T, Yoshida H, Asakawa M, Kawasumi M, Kobayashi T . IL-1β and TNFα-initiated IL-6-STAT3 pathway is critical in mediating inflammatory cytokines and RANKL expression in inflammatory arthritis. Int Immunol. 2011; 23(11):701-12. DOI: 10.1093/intimm/dxr077. View

4.
Chen H, Li X, Liu S, Gu L, Zhou X . MircroRNA-19a promotes vascular inflammation and foam cell formation by targeting HBP-1 in atherogenesis. Sci Rep. 2017; 7(1):12089. PMC: 5608705. DOI: 10.1038/s41598-017-12167-z. View

5.
Li G, Tan W, Fang Y, Wu X, Zhou W, Zhang C . circFADS2 protects LPS-treated chondrocytes from apoptosis acting as an interceptor of miR-498/mTOR cross-talking. Aging (Albany NY). 2019; 11(10):3348-3361. PMC: 6555446. DOI: 10.18632/aging.101986. View